Related Experiment Video
Updated: May 12, 2026

Analysis of Extracellular Vesicle-Mediated Vascular Calcification Using In Vitro and In Vivo Models
Published on: January 27, 2023
Macrophage-derived matrix vesicles: an alternative novel mechanism for microcalcification in atherosclerotic plaques
Sophie E P New1, Claudia Goettsch, Masanori Aikawa
1Center for Interdisciplinary Cardiovascular Sciences, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Rationale:
We previously showed that early calcification of atherosclerotic plaques associates with macrophage accumulation. Chronic renal disease and mineral imbalance accelerate calcification and the subsequent release of matrix vesicles (MVs), precursors of microcalcification.
Objective:
We tested the hypothesis that macrophage-derived MVs contribute directly to microcalcification.
Methods And Results:
Macrophages associated with regions of calcified vesicular structures in human carotid plaques (n=136 patients). In vitro, macrophages released MVs with high calcification and aggregation potential. MVs expressed exosomal markers (CD9 and TSG101) and contained S100A9 and annexin V. Silencing S100A9 in vitro and genetic deficiency in S100A9-/- mice reduced MV calcification, whereas stimulation with S100A9 increased calcification potential. Externalization of phosphatidylserine after Ca/P stimulation and interaction of S100A9 and annexin V indicated that a phosphatidylserine-annexin V-S100A9 membrane complex facilitates hydroxyapatite nucleation within the macrophage-derived MV membrane.
Conclusions:
Our results support the novel concept that macrophages release calcifying MVs enriched in S100A9 and annexin V, which contribute to accelerated microcalcification in chronic renal disease.
Insights
Macrophages release matrix vesicles (MVs) that contribute to microcalcification. These MVs, enriched in S100A9 and annexin V, accelerate calcification, particularly in chronic kidney disease.
Area of Science:
- Cardiovascular Biology
- Vascular Calcification
- Macrophage Biology
Background:
- Early atherosclerotic plaque calcification is linked to macrophage accumulation.
- Chronic kidney disease and mineral imbalance accelerate calcification and matrix vesicle (MV) release.
Purpose of the Study:
- To test the hypothesis that macrophage-derived MVs directly contribute to microcalcification.
- Investigate the role of MVs in the pathogenesis of vascular calcification.
Main Methods:
- Analysis of human carotid plaques for macrophage-associated calcified structures.
- In vitro studies of macrophage-derived MV calcification potential.
- Molecular analysis of MV contents (exosomal markers, S100A9, annexin V).
- In vitro S100A9 silencing and in vivo S100A9 knockout mouse studies.
- Investigation of the phosphatidylserine-annexin V-S100A9 complex in hydroxyapatite nucleation.
Main Results:
- Macrophages were found in calcified regions of human plaques.
- Macrophage-derived MVs exhibited high calcification and aggregation potential in vitro.
- MVs contained exosomal markers, S100A9, and annexin V.
- S100A9 silencing/deficiency reduced MV calcification; S100A9 stimulation increased it.
- A phosphatidylserine-annexin V-S100A9 complex facilitates hydroxyapatite nucleation on MV membranes.
Conclusions:
- Macrophages release calcifying MVs enriched in S100A9 and annexin V.
- These MVs contribute to accelerated microcalcification.
- Findings support a novel mechanism for MV-driven vascular calcification in chronic renal disease.
Related Concept Videos
Atherosclerosis I: Introduction
Inflammation
Coronary Artery Disease II: Pathophysiology

